Figure 1.
Integrin α2β1-dependent platelet adhesion triggers Rap1b activation. (A) Rap1b activation in platelets adherent to different ligands for integrin α2β1 Human platelets were incubated with immobilized BSA, monomeric collagen, the small proteoglycan decorin, or the collagen-derived peptides CB8(II) and CB11(II), as indicated, for 30 minutes. Active Rap1b (Rap1b-GTP) was precipitated with immobilized GST-tagged RalGDS-RBD and identified by immunoblotting with anti-Rap1 antibody. An identical amount of proteins from each cell lysate was also subjected to immunoblotting analysis with the anti-Rap1 antibody to verify the level of the protein in the different samples (Rap1b TOT). (B) None of the analyzed ligands activate platelet GPVI. The GPVI-associated FcR γ-chain was immunoprecipitated from platelets adherent to decorin, CB8(II), CB11(II), monomeric collagen, and convulxin and analyzed by immunoblotting with antiphosphotyrosine antibody (P-Tyr). The same nitrocellulose membranes were then reprobed with anti-FcR γ-chain (bottom panel). (C) Time course of integrin α2β1-dependent platelet adhesion and Rap1b activation. Human platelets were incubated with the 4 different integrin α2β1 ligands for 15, 30, or 60 minutes, as indicated. The percentage of adherent platelets was determined by a colorimetric assay and is reported above the top panel. The immunoblots show active Rap1b (Rap1-GTP) isolated by the pulldown assay with GST-RalGDS-RBD and the level of total Rap1b (Rap1b TOT) present in the lysates used for the Rap1b activation assays.